Proton pump inhibitor treatment is associated with acute-on-chronic liver failure in patients with advanced cirrhosis

Acute-on-chronic liver failure (ACLF) is a fatal complication of cirrhosis. Hence, identification of risk factors for ACLF is crucial. Previous studies have linked proton pump inhibitor (PPI) treatment to complications of cirrhosis, however, a possible effect of PPI treatment on the risk of ACLF has...

Descripción completa

Detalles Bibliográficos
Autores principales: Sturm, Lukas, Gahm, Chiara, Schultheiss, Michael, Reincke, Marlene, Huber, Jan Patrick, Boettler, Tobias, Thimme, Robert, Bettinger, Dominik
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2023
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10289603/
https://www.ncbi.nlm.nih.gov/pubmed/37347229
http://dx.doi.org/10.1097/HC9.0000000000000178

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10289603/
https://www.ncbi.nlm.nih.gov/pubmed/37347229
http://dx.doi.org/10.1097/HC9.0000000000000178

Ejemplares similares